<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-pharmaceuticals-13-00357">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Selvendiran</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vishwanath</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bratasz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Trigg</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Kutala</surname>
    <given-names>V.K.</given-names>
   </name>
   <name>
    <surname>Hideg</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kuppusamy</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression</article-title>
  <source>J. Biol. Chem.</source>
  <year>2007</year>
  <volume>282</volume>
  <fpage>26809</fpage>
  <lpage>26818</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M703796200</pub-id>
 </element-citation>
</ref>
